Murphy Keith 4

4 · ORGANOVO HOLDINGS, INC. · Filed Mar 10, 2021

Form 4

Period: 2021-03-08

DirectorEXECUTIVE CHAIRMAN

Transactions

Award
Stock Option (Right to Buy)
2021-03-08+60,000→ 60,000 total
Exercise: $10.27Exp: 2031-03-08→ Common Stock (60,000 underlying)
Award
Stock Option (Right to Buy)
2021-03-08+45,000→ 45,000 total
Exercise: $10.27Exp: 2031-03-08→ Common Stock (45,000 underlying)
Award
Stock Option (Right to Buy)
2021-03-08+60,000→ 60,000 total
Exercise: $10.27Exp: 2031-03-08→ Common Stock (60,000 underlying)
Award
Common Stock
2021-03-08+20,000→ 66,320 total

Footnotes (4)

[F1]The reported securities are represented by restricted stock units, 25% of which shall vest on March 8, 2022 and the remaining shares vest in 12 equal quarterly installments thereafter.
[F2]25% of the option shares vest and become exercisable on March 8, 2022 and the remaining shares vest in 12 equal quarterly installments thereafter.
[F3]The option becomes exercisable, if at all, if the 45-day moving average closing price of Organovo Holdings, Inc.'s common stock on The Nasdaq Stock Market LLC exceeds $20.00 per share.
[F4]The option becomes exercisable, if at all, if the 45-day moving average closing price of Organovo Holdings, Inc.'s common stock on The Nasdaq Stock Market LLC exceeds $25.00 per share.

Documents

1 file